SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...

Tirzepatide glaucoma risk was lower than with selective glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus ...

A renewed focus on glaucoma comes with each new year, as January is Glaucoma Awareness Month.Glaucoma has been estimated to ...

Prostaglandin analogues, such as latanoprost and bimatoprost, are the go-to therapies for glaucoma therapy. They continue to ...

Most vision loss in India is preventable but often detected too late. Eye surgeon Dr K Subba Rao explains why early screening is crucial for healthy eyesight.

The 10-minute eye test that can protect your vision. Dr. Parul Sony reveals early signs you should never ignore to save your sight. TheHealthSite.com ...

Background Intraocular pressure (IOP) exhibits significant fluctuations in response to changes in body posture. Postural modification may serve as a potential adjunctive strategy for IOP management in ...

To yield the benefits of interventional glaucoma treatment, ophthalmologists need a roadmap for how to implement it, according to a speaker here. At the Hawaiian Eye 2026 meeting, Christine Funke, MD, ...

Taking control of Ocular would also give Sanofi access to its drug delivery platform Elutyx, which could have applications ...

A new study led by investigators from Mass General Brigham shows that a brain waste- "clean-up" system is influenced by ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”), an integrated biopharmaceutical company committed to redefining the retina ...

Within a primary care environment, asynchronous teleophthalmology screening demonstrated effectiveness in detecting ocular ...